Mdivi1 ameliorates mitochondrial dysfunction in non-alcoholic steatohepatitis by inhibiting JNK/MFF signaling.
Ying QuanDiwen ShouSiqi YangJiemin ChengYongqiang LiChen HuangHuiting ChenYong Jian ZhouPublished in: Journal of gastroenterology and hepatology (2023)
Collectively, Mdivi1 protected against diet-induced NASH by restoring mitochondrial homeostasis and function, potentially through its inhibitory effect on the JNK/MFF pathway. Consequently, further investigation of Mdivi1 as a promising drug for NASH treatment is warranted.